Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Adalimumab Biosimilar market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Adalimumab Biosimilar market. Detailed analysis of key players, along with key growth strategies adopted by Adalimumab Biosimilar industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Momenta Pharmaceuticals
Zydus Cadila
Oncobiologics
LG Life Sciences/Mochida Pharmaceutical
Fujifilm Kyowa Kirin Biologics
Pfizer
Samsung Bioepsis
Coherus Biosciences
Amgen
Boehringer Ingelheim
AET BioTech
Sandoz
By Type:
Tablet
Oral Solution
By End-User:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Adalimumab Biosimilar Market
-
1.3 Market Segment by Type
-
1.3.1 China Adalimumab Biosimilar Market Size and Growth Rate of Tablet from 2016 to 2027
-
1.3.2 China Adalimumab Biosimilar Market Size and Growth Rate of Oral Solution from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Adalimumab Biosimilar Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027
-
1.4.2 China Adalimumab Biosimilar Market Size and Growth Rate of Retail Pharmacy from 2016 to 2027
-
1.4.3 China Adalimumab Biosimilar Market Size and Growth Rate of Online Pharmacy from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Adalimumab Biosimilar Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Adalimumab Biosimilar by Major Types
-
3.4.1 Market Size and Growth Rate of Tablet
-
3.4.2 Market Size and Growth Rate of Oral Solution
4 Segmentation of Adalimumab Biosimilar Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Adalimumab Biosimilar by Major End-Users
-
4.4.1 Market Size and Growth Rate of Adalimumab Biosimilar in Hospital Pharmacy
-
4.4.2 Market Size and Growth Rate of Adalimumab Biosimilar in Retail Pharmacy
-
4.4.3 Market Size and Growth Rate of Adalimumab Biosimilar in Online Pharmacy
5 Market Analysis by Regions
-
5.1 China Adalimumab Biosimilar Production Analysis by Regions
-
5.2 China Adalimumab Biosimilar Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Adalimumab Biosimilar Landscape Analysis
-
6.1 North China Adalimumab Biosimilar Landscape Analysis by Major Types
-
6.2 North China Adalimumab Biosimilar Landscape Analysis by Major End-Users
7 Central China Adalimumab Biosimilar Landscape Analysis
-
7.1 Central China Adalimumab Biosimilar Landscape Analysis by Major Types
-
7.2 Central China Adalimumab Biosimilar Landscape Analysis by Major End-Users
8 South China Adalimumab Biosimilar Landscape Analysis
-
8.1 South China Adalimumab Biosimilar Landscape Analysis by Major Types
-
8.2 South China Adalimumab Biosimilar Landscape Analysis by Major End-Users
9 East China Adalimumab Biosimilar Landscape Analysis
-
9.1 East China Adalimumab Biosimilar Landscape Analysis by Major Types
-
9.2 East China Adalimumab Biosimilar Landscape Analysis by Major End-Users
10 Northeast China Adalimumab Biosimilar Landscape Analysis
-
10.1 Northeast China Adalimumab Biosimilar Landscape Analysis by Major Types
-
10.2 Northeast China Adalimumab Biosimilar Landscape Analysis by Major End-Users
11 Southwest China Adalimumab Biosimilar Landscape Analysis
-
11.1 Southwest China Adalimumab Biosimilar Landscape Analysis by Major Types
-
11.2 Southwest China Adalimumab Biosimilar Landscape Analysis by Major End-Users
12 Northwest China Adalimumab Biosimilar Landscape Analysis
-
12.1 Northwest China Adalimumab Biosimilar Landscape Analysis by Major Types
-
12.2 Northwest China Adalimumab Biosimilar Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Momenta Pharmaceuticals
-
13.1.1 Momenta Pharmaceuticals Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Zydus Cadila
-
13.2.1 Zydus Cadila Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Oncobiologics
-
13.3.1 Oncobiologics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 LG Life Sciences/Mochida Pharmaceutical
-
13.4.1 LG Life Sciences/Mochida Pharmaceutical Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Fujifilm Kyowa Kirin Biologics
-
13.5.1 Fujifilm Kyowa Kirin Biologics Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Pfizer
-
13.6.1 Pfizer Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Samsung Bioepsis
-
13.7.1 Samsung Bioepsis Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Coherus Biosciences
-
13.8.1 Coherus Biosciences Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Amgen
-
13.9.1 Amgen Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Boehringer Ingelheim
-
13.10.1 Boehringer Ingelheim Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 AET BioTech
-
13.11.1 AET BioTech Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Sandoz
-
13.12.1 Sandoz Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Adalimumab Biosimilar Market Size and Growth Rate of Tablet from 2016 to 2027
-
Figure China Adalimumab Biosimilar Market Size and Growth Rate of Oral Solution from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Adalimumab Biosimilar Market Size and Growth Rate of Hospital Pharmacy from 2016 to 2027
-
Figure China Adalimumab Biosimilar Market Size and Growth Rate of Retail Pharmacy from 2016 to 2027
-
Figure China Adalimumab Biosimilar Market Size and Growth Rate of Online Pharmacy from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Adalimumab Biosimilar Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Adalimumab Biosimilar Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Adalimumab Biosimilar
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Adalimumab Biosimilar by Different Types from 2016 to 2027
-
Table Consumption Share of Adalimumab Biosimilar by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Tablet
-
Figure Market Size and Growth Rate of Oral Solution
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Adalimumab Biosimilar by Different End-Users from 2016 to 2027
-
Table Consumption Share of Adalimumab Biosimilar by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacy
-
Figure Market Size and Growth Rate of Retail Pharmacy
-
Figure Market Size and Growth Rate of Online Pharmacy
-
Table China Adalimumab Biosimilar Production by Regions
-
Table China Adalimumab Biosimilar Production Share by Regions
-
Figure China Adalimumab Biosimilar Production Share by Regions in 2016
-
Figure China Adalimumab Biosimilar Production Share by Regions in 2021
-
Figure China Adalimumab Biosimilar Production Share by Regions in 2027
-
Table China Adalimumab Biosimilar Consumption by Regions
-
Table China Adalimumab Biosimilar Consumption Share by Regions
-
Figure China Adalimumab Biosimilar Consumption Share by Regions in 2016
-
Figure China Adalimumab Biosimilar Consumption Share by Regions in 2021
-
Figure China Adalimumab Biosimilar Consumption Share by Regions in 2027
-
Table North China Adalimumab Biosimilar Consumption by Types from 2016 to 2027
-
Table North China Adalimumab Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure North China Adalimumab Biosimilar Consumption Share by Types in 2016
-
Figure North China Adalimumab Biosimilar Consumption Share by Types in 2021
-
Figure North China Adalimumab Biosimilar Consumption Share by Types in 2027
-
Table North China Adalimumab Biosimilar Consumption by End-Users from 2016 to 2027
-
Table North China Adalimumab Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure North China Adalimumab Biosimilar Consumption Share by End-Users in 2016
-
Figure North China Adalimumab Biosimilar Consumption Share by End-Users in 2021
-
Figure North China Adalimumab Biosimilar Consumption Share by End-Users in 2027
-
Table Central China Adalimumab Biosimilar Consumption by Types from 2016 to 2027
-
Table Central China Adalimumab Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Central China Adalimumab Biosimilar Consumption Share by Types in 2016
-
Figure Central China Adalimumab Biosimilar Consumption Share by Types in 2021
-
Figure Central China Adalimumab Biosimilar Consumption Share by Types in 2027
-
Table Central China Adalimumab Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Central China Adalimumab Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Adalimumab Biosimilar Consumption Share by End-Users in 2016
-
Figure Central China Adalimumab Biosimilar Consumption Share by End-Users in 2021
-
Figure Central China Adalimumab Biosimilar Consumption Share by End-Users in 2027
-
Table South China Adalimumab Biosimilar Consumption by Types from 2016 to 2027
-
Table South China Adalimumab Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure South China Adalimumab Biosimilar Consumption Share by Types in 2016
-
Figure South China Adalimumab Biosimilar Consumption Share by Types in 2021
-
Figure South China Adalimumab Biosimilar Consumption Share by Types in 2027
-
Table South China Adalimumab Biosimilar Consumption by End-Users from 2016 to 2027
-
Table South China Adalimumab Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure South China Adalimumab Biosimilar Consumption Share by End-Users in 2016
-
Figure South China Adalimumab Biosimilar Consumption Share by End-Users in 2021
-
Figure South China Adalimumab Biosimilar Consumption Share by End-Users in 2027
-
Table East China Adalimumab Biosimilar Consumption by Types from 2016 to 2027
-
Table East China Adalimumab Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure East China Adalimumab Biosimilar Consumption Share by Types in 2016
-
Figure East China Adalimumab Biosimilar Consumption Share by Types in 2021
-
Figure East China Adalimumab Biosimilar Consumption Share by Types in 2027
-
Table East China Adalimumab Biosimilar Consumption by End-Users from 2016 to 2027
-
Table East China Adalimumab Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure East China Adalimumab Biosimilar Consumption Share by End-Users in 2016
-
Figure East China Adalimumab Biosimilar Consumption Share by End-Users in 2021
-
Figure East China Adalimumab Biosimilar Consumption Share by End-Users in 2027
-
Table Northeast China Adalimumab Biosimilar Consumption by Types from 2016 to 2027
-
Table Northeast China Adalimumab Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Adalimumab Biosimilar Consumption Share by Types in 2016
-
Figure Northeast China Adalimumab Biosimilar Consumption Share by Types in 2021
-
Figure Northeast China Adalimumab Biosimilar Consumption Share by Types in 2027
-
Table Northeast China Adalimumab Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Northeast China Adalimumab Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Adalimumab Biosimilar Consumption Share by End-Users in 2016
-
Figure Northeast China Adalimumab Biosimilar Consumption Share by End-Users in 2021
-
Figure Northeast China Adalimumab Biosimilar Consumption Share by End-Users in 2027
-
Table Southwest China Adalimumab Biosimilar Consumption by Types from 2016 to 2027
-
Table Southwest China Adalimumab Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Adalimumab Biosimilar Consumption Share by Types in 2016
-
Figure Southwest China Adalimumab Biosimilar Consumption Share by Types in 2021
-
Figure Southwest China Adalimumab Biosimilar Consumption Share by Types in 2027
-
Table Southwest China Adalimumab Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Southwest China Adalimumab Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Adalimumab Biosimilar Consumption Share by End-Users in 2016
-
Figure Southwest China Adalimumab Biosimilar Consumption Share by End-Users in 2021
-
Figure Southwest China Adalimumab Biosimilar Consumption Share by End-Users in 2027
-
Table Northwest China Adalimumab Biosimilar Consumption by Types from 2016 to 2027
-
Table Northwest China Adalimumab Biosimilar Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Adalimumab Biosimilar Consumption Share by Types in 2016
-
Figure Northwest China Adalimumab Biosimilar Consumption Share by Types in 2021
-
Figure Northwest China Adalimumab Biosimilar Consumption Share by Types in 2027
-
Table Northwest China Adalimumab Biosimilar Consumption by End-Users from 2016 to 2027
-
Table Northwest China Adalimumab Biosimilar Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Adalimumab Biosimilar Consumption Share by End-Users in 2016
-
Figure Northwest China Adalimumab Biosimilar Consumption Share by End-Users in 2021
-
Figure Northwest China Adalimumab Biosimilar Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Momenta Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Momenta Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Momenta Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Momenta Pharmaceuticals
-
Table Product and Service Introduction of Momenta Pharmaceuticals
-
Table Company Profile and Development Status of Zydus Cadila
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zydus Cadila
-
Figure Sales and Growth Rate Analysis of Zydus Cadila
-
Figure Revenue and Market Share Analysis of Zydus Cadila
-
Table Product and Service Introduction of Zydus Cadila
-
Table Company Profile and Development Status of Oncobiologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oncobiologics
-
Figure Sales and Growth Rate Analysis of Oncobiologics
-
Figure Revenue and Market Share Analysis of Oncobiologics
-
Table Product and Service Introduction of Oncobiologics
-
Table Company Profile and Development Status of LG Life Sciences/Mochida Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of LG Life Sciences/Mochida Pharmaceutical
-
Figure Sales and Growth Rate Analysis of LG Life Sciences/Mochida Pharmaceutical
-
Figure Revenue and Market Share Analysis of LG Life Sciences/Mochida Pharmaceutical
-
Table Product and Service Introduction of LG Life Sciences/Mochida Pharmaceutical
-
Table Company Profile and Development Status of Fujifilm Kyowa Kirin Biologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fujifilm Kyowa Kirin Biologics
-
Figure Sales and Growth Rate Analysis of Fujifilm Kyowa Kirin Biologics
-
Figure Revenue and Market Share Analysis of Fujifilm Kyowa Kirin Biologics
-
Table Product and Service Introduction of Fujifilm Kyowa Kirin Biologics
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Samsung Bioepsis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Bioepsis
-
Figure Sales and Growth Rate Analysis of Samsung Bioepsis
-
Figure Revenue and Market Share Analysis of Samsung Bioepsis
-
Table Product and Service Introduction of Samsung Bioepsis
-
Table Company Profile and Development Status of Coherus Biosciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Coherus Biosciences
-
Figure Sales and Growth Rate Analysis of Coherus Biosciences
-
Figure Revenue and Market Share Analysis of Coherus Biosciences
-
Table Product and Service Introduction of Coherus Biosciences
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Boehringer Ingelheim
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim
-
Figure Sales and Growth Rate Analysis of Boehringer Ingelheim
-
Figure Revenue and Market Share Analysis of Boehringer Ingelheim
-
Table Product and Service Introduction of Boehringer Ingelheim
-
Table Company Profile and Development Status of AET BioTech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AET BioTech
-
Figure Sales and Growth Rate Analysis of AET BioTech
-
Figure Revenue and Market Share Analysis of AET BioTech
-
Table Product and Service Introduction of AET BioTech
-
Table Company Profile and Development Status of Sandoz
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz
-
Figure Sales and Growth Rate Analysis of Sandoz
-
Figure Revenue and Market Share Analysis of Sandoz
-
Table Product and Service Introduction of Sandoz
-
